SCA
DXCM icon

Snowden Capital Advisors’s DexCom DXCM Stock Holding History

Snowden Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,932
Closed -$310K – 1356
2026
Q1 		$310K Buy
4,932
+122
+3% +$8.5K 0.01% 1009
2025
Q4 		$319K Sell
4,810
-676
-12% -$43.7K 0.01% 1024
2025
Q3 		$369K Sell
5,486
-150
-3% -$11.9K 0.01% 936
2025
Q2 		$492K Sell
5,636
-2,337
-29% -$183K 0.01% 773
2025
Q1 		$544K Sell
7,973
-197
-2% -$16.1K 0.02% 702
2024
Q4 		$635K Buy
8,170
+1,548
+23% +$115K 0.02% 672
2024
Q3 		$444K Sell
6,622
-1,215
-16% -$99.8K 0.01% 824
2024
Q2 		$889K Buy
7,837
+466
+6% +$58.9K 0.03% 542
2024
Q1 		$1.02M Buy
7,371
+1,803
+32% +$227K 0.03% 498
2023
Q4 		$691K Buy
5,568
+471
+9% +$48.1K 0.03% 553
2023
Q3 		$476K Sell
5,097
-1,978
-28% -$223K 0.02% 678
2023
Q2 		$909K Sell
7,075
-413
-6% -$50K 0.03% 485
2023
Q1 		$870K Sell
7,488
-1,257
-14% -$141K 0.03% 494
2022
Q4 		$990K Buy
8,745
+1,796
+26% +$197K 0.04% 451
2022
Q3 		$559K Buy
6,949
+63
+0.9% +$5.34K 0.03% 606
2022
Q2 		$513K Buy
6,886
+3,322
+93% +$303K 0.02% 618
2022
Q1 		$455K Buy
3,564
+3,352
+1,581% +$367K 0.02% 661
2021
Q4 		$28K Sell
212
-2,136
-91% -$307K ﹤0.01% 1204
2021
Q3 		$321K Buy
2,348
+8
+0.3% +$1.01K 0.02% 665
2021
Q2 		$250K Buy
+2,340
New +$225K 0.01% 772

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Snowden Capital Advisors's DXCM Position: Q2 2026 in Review

Snowden Capital Advisors sold out of DexCom (DXCM) in Q2 2026, closing a stake of 4,932 shares — an estimated $310K sold.

Snowden Capital Advisors first reported a position in DXCM in Q2 2021 and held it in 20 quarters. The position peaked at $1.02M in Q1 2024. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Snowden Capital Advisors reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Snowden Capital Advisors sold 4,932 DexCom shares in Q2 2026, an estimated $310K.
  • Snowden Capital Advisors first reported a position in DexCom in Q2 2021 and held it in 20 quarters.
  • Snowden Capital Advisors's DexCom position peaked at $1.02M in Q1 2024.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Snowden Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.